Jeff Yass’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Jeff Yass’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31,100	Closed	-$1.09M	–	13635
2024 Q1	$1.09M	Sell	31,100 -30,600	-50%	-$1.12M	﹤0.01%	6692
2023 Q4	$2.34M	Buy	+61,700	New	+$1.32M	﹤0.01%	5033
2023 Q3	–	Sell	-15,800	Closed	-$410K	–	13528
2023 Q2	$410K	Sell	15,800 -42,800	-73%	-$1,000K	﹤0.01%	8781
2023 Q1	$1.11M	Buy	58,600 +39,700	+210%	+$923K	﹤0.01%	6543
2022 Q4	$466K	Sell	18,900 -1,500	-7%	-$44.1K	﹤0.01%	8056
2022 Q3	$366K	Buy	+20,400	New	+$368K	﹤0.01%	9305
2022 Q2	–	Sell	-13,200	Closed	-$294K	–	14664
2022 Q1	$294K	Buy	+13,200	New	+$337K	﹤0.01%	10328

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Jeff Yass's INBX Position: Q2 2024 in Review

Jeff Yass sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 63,710 shares — an estimated $2.23M sold.

Jeff Yass first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $4.04M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Jeff Yass reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jeff Yass sold 63,710 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.23M.
Jeff Yass first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
Jeff Yass's Inhibrx, Inc. Common Stock position peaked at $4.04M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.